Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gaalin 8mg modified-release capsules
0411000F0BMAAAE
|
Gaalin | Galantamine | Central Nervous System | 9 |
|
Ketamine 25mg/5ml oral solution
0406000W0AAABAB
|
Ketamine hydrochloride (Nausea) | Ketamine hydrochloride | Central Nervous System | 9 |
|
Lorazepam 250micrograms/5ml oral liquid
0401020P0AABHBH
|
Lorazepam | Lorazepam | Central Nervous System | 9 |
|
Majoven XL 150mg capsules
0403040W0CFACAE
|
Majoven | Venlafaxine | Central Nervous System | 9 |
|
Methylphenidate 10mg/5ml oral solution
0404000M0AAACAC
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | 9 |
|
Nefazodone 100mg tablets
0403040T0AAAAAA
|
Nefazodone hydrochloride | Nefazodone hydrochloride | Central Nervous System | 9 |
|
Olanzapine 7.5mg orodispersible tablets sugar free
040201060AABHBH
|
Olanzapine | Olanzapine | Central Nervous System | 9 |
|
Ondansetron 4mg/5ml oral liquid
0406000S0AAAFAF
|
Ondansetron hydrochloride | Ondansetron hydrochloride | Central Nervous System | 9 |
|
Primidone 25mg/5ml oral suspension
0408010U0AAACAC
|
Primidone | Primidone | Central Nervous System | 9 |
|
Sertraline 150mg/5ml oral suspension
0403030Q0AAAKAK
|
Sertraline hydrochloride | Sertraline hydrochloride | Central Nervous System | 9 |
|
Tapentadol 150mg modified-release capsules
0407020AGAAALAL
|
Tapentadol | Tapentadol | Central Nervous System | 9 |
|
Tryptophan 500mg tablets
0403040S0AAABAB
|
Tryptophan | Tryptophan | Central Nervous System | 9 |
|
Zispin SolTab 30mg orodispersible tablets
0403040X0BBABAJ
|
Zispin | Mirtazapine | Central Nervous System | 9 |
|
Alvedon 125mg suppositories
0407010H0CDAACM
|
Alvedon | Paracetamol | Central Nervous System | 8 |
|
Buprenorphine 16mg/0.32ml prolonged-release inj pfs
0410030A0AAAPAP
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | 8 |
|
Clonidine 100micrograms/5ml oral liquid
0407042F0AAALAL
|
Clonidine hydrochloride (Migraine) | Clonidine hydrochloride | Central Nervous System | 8 |
|
Clozapine 50mg/ml oral suspension sugar free
0402010C0AAAEAE
|
Clozapine | Clozapine | Central Nervous System | 8 |
|
Diazepam 25mg/5ml oral solution
0401020K0AABMBM
|
Diazepam | Diazepam | Central Nervous System | 8 |
|
Icenia Melatonin 3mg capsules
0401010ADBCCBBR
|
Melatonin (Proprietary preparations) | Melatonin | Central Nervous System | 8 |
|
Ixyldone 15mg modified-release tablets
0407020ADBTACAS
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 8 |
|
Ketamine 500mg/5ml oral solution
0406000W0AAALAL
|
Ketamine hydrochloride (Nausea) | Ketamine hydrochloride | Central Nervous System | 8 |
|
Melatonin 3mg modified-release tablets
0401010ADAAAQAQ
|
Melatonin | Melatonin | Central Nervous System | 8 |
|
Midazolam 5mg/5ml oral liquid
0408020V0AAADAD
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | 8 |
|
Morphine sulfate 500micrograms/5ml oral solution
0407020Q0AAFDFD
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 8 |
|
Morphine sulfate 5mg/5ml oral solution
0407020Q0AADNDN
|
Morphine sulfate | Morphine sulfate | Central Nervous System | 8 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.